These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 640498)

  • 21. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Freitas JE; Grekin RJ; Thrall JH; Gross MD; Swanson DP; Beierwaltes WH
    J Nucl Med; 1979 Jan; 20(1):7-10. PubMed ID: 430181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
    Ryo UY; Johnston AS; Kim I; Pinsky SM
    Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic significance of the various radiological examinations in adrenal disease.
    Sasaki T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 May; 38(5):416-22. PubMed ID: 693258
    [No Abstract]   [Full Text] [Related]  

  • 24. Seeking the invisible: I-131 NP-59 SPECT/CT for primary hyperaldosteronism.
    Chen YC; Wei CK; Chen PF; Tzeng JE; Chuang TL; Wang YF
    Kidney Int; 2009 Mar; 75(6):663. PubMed ID: 19247385
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of 19-indocholesterol and 6-iodomethylnorcholesterol as adrenal scanning agents.
    Kraychy S; Leeper MA
    J Nucl Med; 1978 Mar; 19(3):333-4. PubMed ID: 632918
    [No Abstract]   [Full Text] [Related]  

  • 26. Adrenal imaging with 131I-19-iodocholesterol in the diagnostic evaluation of patients with aldosteronism.
    Seabold JE; Cohen EL; Beierwaltes WH; Hinerman DL; Nishiyama RH; Bookstein JJ; Ice RD; Balachandran S
    J Clin Endocrinol Metab; 1976 Jan; 42(1):41-51. PubMed ID: 1249193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal scintiscanning and aldosteronism.
    Gross MD; Freitas JE; Thrall JH; Grekin RJ; Beierwaltes WH
    Ann Intern Med; 1979 Oct; 91(4):651-2. PubMed ID: 484977
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adrenal phlebography in primary hyperaldosteronism].
    Feltrin GP; Maffessanti M; Miotto M; Mantero F; ArmaniniD ; Boscaro M
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():509-10. PubMed ID: 1232303
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure to visualize bilateral adrenal glands in a patient with primary aldosteronism.
    Seino M; Abe K; Imai Y; Murakami O; Kasai Y; Sasaki S; Minami N; Munakata M; Kanazawa M; Takeuchi K
    Clin Exp Hypertens A; 1990; 12(1):37-46. PubMed ID: 2155075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-(125I) Iodo-5-cholestene: rationale for its development as a potential adrenal scanning agent.
    Owoyale JA; Szinai SS
    Acta Pharm Suec; 1981; 18(4):227-32. PubMed ID: 7315367
    [No Abstract]   [Full Text] [Related]  

  • 31. [Improved scintigraphic imaging of the adrenals with 6beta-131I-iodomethyl-cholesterol (author's transl)].
    Tragl KH; Angelberger P; Pils P; Wiesinger F; Kletter K
    Rofo; 1977 Oct; 127(4):365-9. PubMed ID: 144660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. I. Analysis of normal adrenal images.
    Nakajo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):985-97. PubMed ID: 7335472
    [No Abstract]   [Full Text] [Related]  

  • 33. Computed tomography of adrenal glands.
    Reynes CJ; Churchill R; Moncada R; Love L
    Radiol Clin North Am; 1979 Apr; 17(1):91-104. PubMed ID: 461744
    [No Abstract]   [Full Text] [Related]  

  • 34. [The significance of gamma scintigraphy in primary hyperaldosteronism].
    Pöyhönen L; Siitonen L; Markkula H
    Duodecim; 1979; 95(17):1067-73. PubMed ID: 520218
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adrenal scintigraphy in the patients with primary aldosteronism: localizing and differential diagnosis by dexamethasone suppression scintigraphy (author's transl)].
    Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
    Kaku Igaku; 1978 Jun; 15(4):545-51. PubMed ID: 702930
    [No Abstract]   [Full Text] [Related]  

  • 36. [Scintigraphy of the adrenals using 19-iodocholesterol-131I].
    Zubovskiĭ GA; Turaev RN; Marova EI
    Med Radiol (Mosk); 1978 Jan; 23(1):45-9. PubMed ID: 342859
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
    Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
    Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
    [No Abstract]   [Full Text] [Related]  

  • 38. Radioisotopic study of the adrenal glands using 131I-19-iodocholesterol.
    Troncone L; Galli G; Salvo D; Barbarino A; Bonomo L
    Br J Radiol; 1977 May; 50(593):340-9. PubMed ID: 861453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adrenal scanning using 19-iodocholesterol-I131].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Markov VV; Iakovlev AA
    Vrach Delo; 1979 Jul; (7):32-5. PubMed ID: 473741
    [No Abstract]   [Full Text] [Related]  

  • 40. Imaging the adrenal glands with radiolabeled inhibitors of enzymes: concise communication.
    Beierwaltes WH; Wieland DM; Mosley ST; Swanson DP; Sarkar SD; Freitas JE; Thrall JH; Herwig KR
    J Nucl Med; 1978 Feb; 19(2):200-3. PubMed ID: 627901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.